Day 1 September 09, 2019 Zurich Opening Ceremony. Keynote Forum

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "Day 1 September 09, 2019 Zurich Opening Ceremony. Keynote Forum"

Transcription

1 09:00-09:30 09:30-10:15 10:15-11:00 Day 1 September 09, 2019 Zurich Opening Ceremony Keynote Forum Title: Novel molecules trapped into biocompatible drug delivery systems direct to solid tumors Dr. Carmela Saturnino,University of Basilicata, Italy Title: Onnetsu-Invisible Oncology Dr.Kazuko Tatsumura Director, Gaia Holistic Health, USA Group Photo Networking & Refreshments Break Foyer Cancer Cell Biology l Cancer Biomarkers l Cancer Vaccines Chair : Dr. Heike Pohla, Munich Unversity Hospitals,Germany Co Chair : Dr.Robert Watson, National Cancer Research Institute,UK 11:15-11:50 11:50-12:25 14:00-14:35 14:35-15:10 15:30-16:00 16:00-16:30 16:30-17:00 Title: Identification and validation of HLA-A24 XBP1, CD138, and CS1 peptides and induction of antigensspecific CD8+ T cell immunity using a multipeptide cocktail: preclinical basis for vaccine therapy in HLA-A24 patients with multiple myeloma and other cancers Prof.Jooeun Bae, Dana-Farber Cancer Institute, USA Title: Mesenchymal stem cells in inflammatory microenvironment promotes cancer cell migration and epithelial-mesenchymal transition through osteopontin Dr. Heike Pohla Head of the Tumor Immunology Laboratory,Munich University Hospital,Germany Lunch Break Title: Validation of a Novel Therapeutic Target for Targeted Radionuclide-Antibody Therapy of Malignant Pleural Effusion Jaecheong Lim, Korea Atomic Energy Research Institute, Republic of Korea Title: Brazilian natural compound FLAV5: A promising anticancer drug Giovanna Barbarini Longato, University of San Francisco, USA Networking & Refreshments Break: Young Researchers Forum Title: High expression of Pyruvate Dehydrogenase Kinase in Cholangiocarcinoma patients Divya Ram Jayram, Ben-Gurien University of Negev,Isreal Title: Serum apurinic/apyrimidinic endodeoxyribonuclease 1 in cholangiocarcinoma patients Doungdean Tummanatsakun, Khon Kaen University, Thailand Title: High expression of Pyruvate Dehydrogenase Kinase in Cholangiocarcinoma patients Daraporn Chua-on, Khon Kaen University, Japan Panel Discussion

2 Day 2 September 10, 2019 Kagayaki Keynote Forum 10:00-10:45 10:45-11:30 11:45-12:20 Title: MicroRNA expression in advanced breast cancer Stefan Glueck Professor of Medicine,Celgene Corporation,USA Title: mirnacancermap: A web server prioritizing tumor associated mirna Prof.Dr.P.H.Krammer, German Cancer Research Center,Germany Chair : Lei Huo, University of Texas, USA Co Chair : Jiangwen Zhang, The University of Hong Kong, Hong Kong SAR Cancer Treatment and Therapeutics l Cancer Research Networking & Refreshments Break Foyer Title: Sphk2 inhibitor ABC enhances cell death in NSCLC cells via downregulation and proteasomedependent degradation of c-flipl Mr.Daniel Vitale, The University of Sydney,Australia 12:20-12:55 Title: The potential of circulating tumor cells (CTCs) in personalized management of breast cancer: A systematic review Fatemeh Khatami, University of Medical Sciences, Spain GCC 01 GCC 02 GCC 03 GCC 04 GCC 05 GCC 06 GCC 07 Lunch Break 1F Restaurant the Café Poster Presentation 14:00-16:00 Title: Targeted CT contrast agents for molecular imaging of cancer based on cathepsins' elevated activity Darya Tsvirkun, The Hebrew University, Israel Title: Using anti-poly(ethylene glycol) bioparticles for the quantitation of PEGylated nanoparticles Dr.Romina Rosch,German Cancer Research Center,Germany Title: Development of bacterial glucuronidase specific inhibitors to reduce chemo-induced intestinal toxicity and diarrhea Jaunting Haung,University of Beijing, China Title: Optimizations of anti-peg sandwich ELISA for quantification of PEGylated molecules Ming-yang Tseng, Kaohsiung Medical University, Taiwan Title: Optimization of an anti-poly(ethylene glycol) (anti-peg) cell-based capture system to quantify PEG and PEGylated molecules Wen-Wei Lin, National Sun Yat-sen University, Taiwan Title: Acetylated mangostin alleviates many anticancer effects of mangostin at the molecular levels Han-Heom Na, Kangwon National University, Republic of Korea Keun-Cheol Kim, Kangwon National University, Republic of Korea Title: ERK regulates liver cirrhosis and hepatocellular carcinoma

3 GCC 08 GCC 09 Abeer Muhanna, Saudi Cancer Research Center, Saudi Arabia Title: Snail-induced claudin-11 engenders collective migration and forms circulating tumor cell clusters to promote tumor progression Miss. Mary Alexandra, Blokhin Russian Cancer Research Centre,Russia Title: Apoptotic effect of Prunus spinosa fruit extract on HT-29 colon cancer cell line Egzona Qipa, Trakya University, Turkey Networking & Refreshments Break: Foyer Poster Evalution Award Ceremony Networking and :00 1F Restaurant the Café Our Collabrators:

4 Our Media Partners:

5